119 related articles for article (PubMed ID: 38706199)
1. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
[TBL] [Abstract][Full Text] [Related]
2. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
[TBL] [Abstract][Full Text] [Related]
4. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
5. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
8. Medication Overuse and Headache Burden: Results From the CaMEO Study.
Schwedt TJ; Buse DC; Argoff CE; Reed ML; Fanning KM; Hussar CR; Adams AM; Lipton RB
Neurol Clin Pract; 2021 Jun; 11(3):216-226. PubMed ID: 34476122
[TBL] [Abstract][Full Text] [Related]
9. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Dodick DW; Loder EW; Manack Adams A; Buse DC; Fanning KM; Reed ML; Lipton RB
Headache; 2016 May; 56(5):821-834. PubMed ID: 27143127
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
[TBL] [Abstract][Full Text] [Related]
11. Headache-related health resource utilisation in chronic and episodic migraine across six countries.
Sanderson JC; Devine EB; Lipton RB; Bloudek LM; Varon SF; Blumenfeld AM; Goadsby PJ; Buse DC; Sullivan SD
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1309-17. PubMed ID: 23813744
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
15. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942
[TBL] [Abstract][Full Text] [Related]
16. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
[TBL] [Abstract][Full Text] [Related]
17. Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Buse DC; Nahas SJ; Stewart WBF; Armand CE; Reed ML; Fanning KM; Manack Adams A; Lipton RB
J Occup Environ Med; 2023 Apr; 65(4):e261-e268. PubMed ID: 36701797
[TBL] [Abstract][Full Text] [Related]
18. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
[TBL] [Abstract][Full Text] [Related]
19. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
[TBL] [Abstract][Full Text] [Related]
20. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
Lipton RB; Pozo-Rosich P; Orr SL; Reed ML; Fanning KM; Dabruzzo B; Buse DC
Headache; 2023; 63(10):1448-1457. PubMed ID: 37795746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
